» Articles » PMID: 34023359

Leveraging Vertical COVID-19 Investments to Improve Monitoring of Cancer Screening Programme - A Case Study from Bangladesh

Overview
Journal Prev Med
Specialty Public Health
Date 2021 May 23
PMID 34023359
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer screening programs from majority of the low- and middle-income countries (LMICs) report screening coverage as the only performance indicator, and that too measured through population-based sample surveys. Such information is unreliable and has very little value in assessing programmatic quality and impact. Regular monitoring of key process and outcome indicators based on data collected through a robust information system is essential to ensure quality of a screening programme. Fragmented health systems, limited resources and absence of a culture of systematic evaluation are the major hindrances for most of the LMICs to build electronic information systems to manage screening. The COVID-19 pandemic has created an impetus for the countries to customize the freely available District Health Information Software (DHIS2) to collect electronic data to track the outbreaks and manage containment measures. In the present article we present Bangladesh as an exemplar LMIC that has a (DHIS2) based integrated health information system gradually upgraded to collect individual data of the participants to the national cervical cancer screening program. Such efforts paid rich dividends as the screening program was switched from opportunistic to a population-based one. Moreover, the electronic system could report impact of the pandemic on cancer screening on a monthly basis. The aggregate number of women screened in the year 2020 was 14.1% less compared to 2019. The monthly rate of screening during peak of the outbreak was only 5.1% of the previous year. The rate rapidly recovered as the program intensified screening in the hard-to-reach regions less affected by the pandemic and expanded the outreach services. Other LMICs may emulate Bangladesh example. Customizing the information system developed for pandemic surveillance to collect cancer screening data will help them build back the screening programs better.

Citing Articles

Establishing a cancer registry and baseline data for Nyandarua County, Kenya: A step towards establishing a central cancer registry.

Kamita M, Waweru H, Githinji M, Kibiro E, Makokha F Heliyon. 2024; 10(20):e39056.

PMID: 39492911 PMC: 11530777. DOI: 10.1016/j.heliyon.2024.e39056.


From barriers to opportunities from COVID-19 pandemic: Stakeholder perspectives on cervical cancer screening programs in LMICs of the Asia-Pacific region.

Lee J, Ismail-Pratt I, Machalek D, Kumarasamy S, Garland S PLOS Glob Public Health. 2024; 4(10):e0003768.

PMID: 39365795 PMC: 11451976. DOI: 10.1371/journal.pgph.0003768.


Breast cancer and cervical cancer: a comparison of the period before and during the COVID-19 pandemic.

Stevanato K, Dos Santos L, Pelloso F, Pelloso Borghesan D, Consolaro M, de Almeida R BMC Womens Health. 2024; 24(1):485.

PMID: 39227848 PMC: 11370265. DOI: 10.1186/s12905-024-03325-3.


Electronic aggregated data collection on cervical cancer screening in Bangladesh since 2014: what the data tells us?.

Nessa A, Hossain M, Uddin S, Islam M, Khan M, Azad A BMC Public Health. 2024; 24(1):270.

PMID: 38263029 PMC: 10804837. DOI: 10.1186/s12889-023-17545-z.


Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis.

Steinberg J, Hughes S, Hui H, Allsop M, Egger S, David M Int J Cancer. 2023; 154(8):1394-1412.

PMID: 38083979 PMC: 10922788. DOI: 10.1002/ijc.34798.


References
1.
Basu P, Selmouni F, Belakhel L, Sauvaget C, Abousselham L, Lucas E . Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance. Int J Cancer. 2018; 143(12):3273-3280. PMC: 6637920. DOI: 10.1002/ijc.31749. View

2.
Majek O, Anttila A, Arbyn M, Van Veen E, Engesaeter B, Lonnberg S . The legal framework for European cervical cancer screening programmes. Eur J Public Health. 2018; 29(2):345-350. DOI: 10.1093/eurpub/cky200. View

3.
El Bcheraoui C, Weishaar H, Pozo-Martin F, Hanefeld J . Assessing COVID-19 through the lens of health systems' preparedness: time for a change. Global Health. 2020; 16(1):112. PMC: 7675393. DOI: 10.1186/s12992-020-00645-5. View

4.
Jansen E, Zielonke N, Gini A, Anttila A, Segnan N, Voko Z . Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020; 127:207-223. DOI: 10.1016/j.ejca.2019.12.013. View

5.
Anttila A, Lonnberg S, Ponti A, Suonio E, Villain P, Coebergh J . Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries. Eur J Cancer. 2014; 51(2):241-51. DOI: 10.1016/j.ejca.2014.10.022. View